Ultrasound-guided injection of triamcinolone and bupivacaine in the management of de Quervain′s disease

Jeyapalan, Kanagaratnam; Choudhary, Surabhi

doi:10.1007/s00256-009-0721-y

Cited by 56 publications

(42 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Our results confirm data in the literature regarding the superiority of ultrasound guidance above palpation in terms of the incidence of complications [10]. Minor complications including skin depigmentation and subcutaneous fat atrophy have been reported in up to 36 % of palpation-guided procedures [26], while no complications were reported in the present paper and in previous experiences using steroids [10].…”

Section: Discussionsupporting

confidence: 94%

“…Minor complications including skin depigmentation and subcutaneous fat atrophy have been reported in up to 36 % of palpation-guided procedures [26], while no complications were reported in the present paper and in previous experiences using steroids [10]. Of note, while steroids quite easily spread through the tissues, HA exerts its action only when injected exactly into the synovial space.…”

Section: Discussionmentioning

confidence: 50%

“…Studies about ultrasound-guided steroid injections to treat de Quervain's disease reported pain relief in most cases but with a not negligible rate of recurrence. [10,11]. Moreover, some authors report that the presence of a subcompartment-dividing septum or supernumerary tendons could impair the outcome of injection treatments [3][4][5]12].…”

mentioning

confidence: 96%

See 2 more Smart Citations

Ultrasound-guided percutaneous injection to treat de Quervain’s disease using three different techniques: a randomized controlled trial

et al. 2014

View full text Add to dashboard Cite

show abstract

Section: Discussionsupporting

confidence: 94%

Section: Discussionmentioning

confidence: 50%

See 1 more Smart Citation

Ultrasound-guided percutaneous injection to treat de Quervain’s disease using three different techniques: a randomized controlled trial

et al. 2014

View full text Add to dashboard Cite

show abstract

“…In those cases when a tendinitis or a tenosynovitis is present, a corticosteroid instillation in the tendon sheath can also reduce synovial inflammation and improving symptoms (Fig. 3) [1]. Yttrium-90 radiation synovectomy or radiosynoviorthesis (RSO) is another therapeutic technique based on an intra-articular image-guided infusion of a radionuclide.…”

Section: Introductionmentioning

confidence: 99%

US-guided interventional joint procedures in patients with rheumatic diseases—When and how we do it?

Gonçalves

Ambrósio

Serra

et al. 2011

European Journal of Radiology

View full text Add to dashboard Cite

a b s t r a c tObjective: To describe the main indications and the technical steps to perform ultrasound guided procedures in patients with rheumatic diseases. To access procedures accuracy, safety and effectiveness. Materials and methods: 27 patients with pain related to articular complications of rheumatic diseases and according to previous radiographic or US exam were submitted to several US-guided procedures. 42% of patients (n = 11) had rheumatoid arthritis, 11% (n = 3) spondyloarthropathies, 18% (n = 5) psoriatic arthritis, 15% (n = 4) undifferentiated arthritis, 3% (n = 1) Sjögren syndrome and 11% (n = 3) had gout.Described procedures are synovial biopsies, intra-articular injections of corticosteroids, radiation synovectomy and synovial cysts drainage procedures. When a therapeutical procedure was made, patients were evaluated by 2 rheumatologists.Corticosteroids used were Prednisolone and Triamcinolone. Yttrium-90 was used for synovectomy. Results: In all cases success was achieved with correct needle placement inside the joint. After injection/aspiration symptoms successfully solved with all patients improving their health status. No complications were recorded during follow-up period. Conclusions: US-guidance is very reliable to afford a safety procedure always checking the injection, biopsy or aspiration. Guided-biopsy has high success rates obtaining several samples. Thus is also possible to use more powerful/long acting therapeutic drugs aggressive to extra-articular structures avoiding complications.

show abstract

“…Retrospective and prospective cohort studies report improvements in most patients, but often over long time periods [6,11,16].…”

Section: Discussionmentioning

confidence: 99%

Disability and Pain after Cortisone versus Placebo Injection for Trapeziometacarpal Arthrosis and De Quervain Syndrome

Makarawung

Becker

Bekkers

et al. 2013

Hand (New York, N,Y.)

View full text Add to dashboard Cite

Background This study tested the null hypothesis that type of injection (corticosteroid vs. placebo) is not a predictor of arm-specific disability as measured with the Disabilities of Arm, Shoulder and Hand questionnaire 1 to 3 months after injection of dexamethasone or placebo for treatment of trapeziometacarpal (TMC) arthrosis or de Quervain syndrome. Secondly, we tested if type of injection was a predictor of pain intensity. Methods Thirty-six English-speaking adults with TMC arthrosis or de Quervain syndrome were randomized for a dexamethasone or a placebo injection. At time of the injection, patients completed a demographic data sheet and validated questionnaires assessing arm-specific disability, pain intensity, depressive symptoms, pain catastrophizing, and patient's health-related beliefs. At an average of 1.4 ± 0.42 months (range, 0.79-2.5 months) after the injection, patients completed questionnaires regarding arm-specific disability, pain, and treatment satisfaction. Grip and pinch strength measurements were measured at both time points. Bivariable and multivariable analyses assessed predictors of arm-specific disability and pain intensity at follow-up. Results Type of injection was not a predictor of arm-specific disability or pain intensity 1 to 3 months after injection. The best model both for arm-specific disability and pain intensity at follow-up included pain catastrophizing and explained 18 % and 33 % of the variability, respectively. Conclusions Catastrophic thinking was a better predictor of both of arm-specific disability and pain intensity than diagnosis or type of injection (steroid vs. placebo) 1to 3 months after an injection.

show abstract

Ultrasound-guided injection of triamcinolone and bupivacaine in the management of de Quervain′s disease

Abstract: Ultrasound-guided injection of triamcinolone and bupivacaine is safe and useful in controlling symptoms of De Quervain's disease. Correct needle placement with ultrasound guidance avoids intratendinous injection as well as local complications like fat atrophy and depigmentation.

Cited by 56 publications

References 7 publications

Ultrasound-guided percutaneous injection to treat de Quervain’s disease using three different techniques: a randomized controlled trial

Ultrasound-guided percutaneous injection to treat de Quervain’s disease using three different techniques: a randomized controlled trial

US-guided interventional joint procedures in patients with rheumatic diseases—When and how we do it?

Disability and Pain after Cortisone versus Placebo Injection for Trapeziometacarpal Arthrosis and De Quervain Syndrome

Contact Info

Product

Resources

About